ylliX - Online Advertising Network
Video News

23andMe CEO on Trading Debut, GSK Deal, Branson SPAC

<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>

Jun.17 — 23andMe Inc. CEO Anne Wojcicki discusses the DNA-testing company’s NASDAQ trading debut, a collaboration on drug development with GlaxoSmithKline Plc, and the choice to go public through a merger with VG Acquisition Corp., a special-purpose acquisition company founded by billionaire Richard Branson. She speaks with Bloomberg’s Emily Chang on “Bloomberg Markets: The Close.

...read full article on Bloomberg Technology

ylliX - Online Advertising Network